延伸护理在非小细胞肺癌患者阿替利珠单抗免疫治疗中的应用效果

doi:10.3760/cma.j.issn.1007-1245.2024.06.007

摘要/Abstract

摘要：

目的　探讨延伸护理在非小细胞肺癌患者阿替利珠单抗免疫治疗期间的应用效果。方法　本研究为随机对照试验。根据随机数字表法将2019年3月至2022年3月于河南省肿瘤医院就诊的102例非小细胞肺癌患者分为对照组（51例）和观察组（51例）。对照组患者中男性30例，女性21例，年龄（62.39±5.16）岁；Ⅱ期3例，Ⅲ期29例，Ⅳ期19例；观察组患者中男性31例，女性20例，年龄（62.47±5.22）岁；Ⅱ期2例，Ⅲ期31例，Ⅳ期18例。两组患者手术切除后均采用顺铂联合阿替利珠单抗进行治疗，3周为1个疗程，连续治疗4个疗程。在治疗期间予以对照组患者常规护理，观察组患者在对照组的基础上进行延伸护理。比较两组患者遵医嘱行为情况，干预前后的生存质量、心理状态，护理满意度。采用t检验、χ²检验。结果　对照组按嘱用药、坚持锻炼、合理饮食、情绪良好患者占比［70.59%（36/51）、68.63%（35/51）、64.71%（33/51）、66.67%（34/51）］均低于观察组［（94.12%（48/51）、88.24%（45/51）、90.20%（46/51）、92.16%（47/51）］，差异均有统计学意义（χ²=9.714、5.795、9.487、10.134，P=0.002、0.016、0.002、0.001）。干预后，两组患者的躯体功能、睡眠质量、情绪功能、认知功能、社会功能、角色功能评分均较干预前升高，且观察组［（75.69±4.13）分、（72.88±3.87）分、（71.33±4.57）分、（70.82±5.03）分、（72.77±4.66）分、（77.17±3.89）分］均高于对照组［（64.94±4.82）分、（63.72±3.96）分、（63.49±4.25）分、（62.49±5.17）分、（64.49±5.12）分、（66.38±3.94）分］；两组患者的焦虑、抑郁、精神病性症状评分均较干预前降低，且观察组［（1.36±0.32）分、（1.32±0.31）分、（1.14±0.29）分］均低于对照组［（1.73±0.38）分、（1.69±0.33）分、（1.59±0.36）分］，差异均有统计学意义（均P<0.05）。观察组患者的护理总满意度高于对照组［96.08%（49/51）比82.35%（42/51）］（χ²=4.993，P=0.025）。结论　延伸护理在非小细胞肺癌患者阿替利珠单抗免疫治疗期间效果确切，可有效改善患者生活质量与心理状态，提高患者的遵医行为与护理满意度。

关键词:

非小细胞肺癌, 阿替利珠单抗, 免疫治疗, 延伸护理

Abstract:

Objective　To explore the application effect of extended care during the immunotherapy period with atezolizumab for postoperative non-small cell lung cancer patients. Methods　This study was a randomized controlled trial. According to the random number table method, 102 non-small cell lung cancer patients who visited Henan Cancer Hospital from March 2019 to March 2022 were divided into a control group (51 cases) and an observation group (51 cases). There were 30 males and 21 females in the control group, aged (62.39±5.16) years, 3 cases in stage Ⅱ, 29 cases in stage Ⅲ, and 19 cases in stage Ⅳ. There were 31 males and 20 females in the observation group, aged (62.47±5.22) years, 2 cases in stage Ⅱ, 31 cases in stage Ⅲ, and 18 cases in stage Ⅳ. Both groups were treated with cisplatin combined with attillizumab for 4 consecutive courses of treatment with 3 weeks as 1 course. During the treatment period, routine care was given to the control group, while extended care was given to the observation group on the basis of the control group. The compliance behaviors, quality of life and psychological status before and after intervention, and nursing satisfaction were compared between the two groups. t test and χ² test were used. Results　The proportions of the patients in the control group who took medication as prescribed, persisted in exercise, had a reasonable diet, and had good emotions [70.59% (36/51), 68.63% (35/51), 64.71% (33/51), and 66.67% (34/51)] were lower than those in observation group [94.12% (48/51), 88.24% (45/51), 90.20% (46/51), and 92.16% (47/51)], with statistically significant differences (χ²=9.714, 5.795, 9.487, and 10.134, P=0.002, 0.016, 0.002, and 0.001). After intervention, the scores of physical function, sleep quality, emotional function, cognitive function, social function, and role function in both groups were higher than those before intervention, and those in the observation group [(75.69±4.13) points, (72.88±3.87) points, (71.33±4.57) points, (70.82±5.03) points, (72.77±4.66) points, and (77.17±3.89) points] were higher than those in the control group [(64.94±4.82) points, (63.72±3.96) points, (63.49±4.25) points, (62.49±5.17) points, (64.49±5.12) points, and (66.38±3.94) points], with statistically significant differences (all P<0.05). After intervention, the scores of anxiety, depression, and psychosis in both groups were lower than those before intervention, and those in the observation group [(1.36±0.32) points, (1.32±0.31) points, and (1.14±0.29) points] were lower than those in the control group [(1.73±0.38) points, (1.69±0.33) points, and (1.59±0.36) points], with statistically significant differences (all P<0.05). The overall nursing satisfaction in the observation group was higher than that in the control group [96.08% (49/51) vs. 82.35% (42/51)] (χ²=4.993, P=0.025). Conclusion　Extended care has a definite effect during the postoperative atezolizumab immunotherapy period for non-small cell lung cancer, which can effectively improve the patients' quality of life and psychological status, enhance their compliance behaviors and nursing satisfaction.

Key words:

Non-small cell lung cancer, Atezolizumab, Immunotherapy, Extended care

陈荔蕊苏照坤高亚娜.

延伸护理在非小细胞肺癌患者阿替利珠单抗免疫治疗中的应用效果 [J]. 国际医药卫生导报, 2024, 30(6): 918-922.

Chen Lirui, Su Zhaokun, Gao Yana.

Application effect of extended care during atezolizumab immunotherapy in non-small cell lung cancer patients [J]. International Medicine and Health Guidance News, 2024, 30(6): 918-922.

参考文献

[1] Pennell NA, Arcila ME, Gandara DR, et al. Biomarker testing for patients with advanced non-small cell lung cancer: real-world issues and tough choices[J]. Am Soc Clin Oncol Educ Book, 2019,39:531-542. DOI: 10.1200/EDBK_237863.
[2] Remon J, Soria JC, Peters S, et al. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy[J]. Ann Oncol, 2021, 32(12):1637-1642. DOI: 10.1016/j.annonc.2021.08.1994.
[3] 金倩晨,姜佳宁,吕金燕,等. 阿特珠单抗、贝伐珠单抗联合化疗治疗EGFR-TKIs耐药后晚期非小细胞肺癌1例并文献复习[J]. 中国医药科学,2021,11(4):239-241. DOI: 10.3969/j.issn.2095-0616.2021.04.065.
[4] 鲁晓莉. 延伸护理用于癌症化疗护理中的效果观察[J/CD]. 临床医药文献电子杂志,2019,6(61):101. DOI: 10.16281/j.cnki.jocml.2019.61.087.
[5] 方涛,雷想,宋兵. 阿特珠单抗在肺癌治疗中的研究进展[J]. 中国胸心血管外科临床杂志,2022,29(1):114-120. DOI: 10.7507/1007-4848.202008037.
[6] 王娟,陈德凤,刘勇世,等. 延伸护理对肺癌患者术后生存时间及生活质量的影响[J]. 临床医学研究与实践,2021,6(4):150-152. DOI: 10.19347/j.cnki.2096-1413.202104052.
[7] 汪凤兰. 延伸护理对肺癌根治术后患者生活质量的影响[J]. 中外医疗,2020,39(18):108-110. DOI: 10.16662/j.cnki.1674-0742.2020.18.108.
[8] 陈炎,陈亚蓓,陶荣芳,等. «CSCO原发性肺癌诊疗指南2016»非小细胞肺癌治疗内容介绍[J]. 中国实用内科杂志,2017, 37(S1):35-37. DOI: 10.19538/j.nk2017SI0112.
[9] 王岩,朱琳,陈鹏. 肿瘤患者生命质量测定量表EORTC QLQ-C30维文版评价[J]. 中国卫生统计,2015,32(3):512-513.
[10] 叶旺娣. 突发性耳聋症状自评量表-SCL90的测评分析及护理对策的研究[J/CD]. 实用临床护理学电子杂志,2017,2(38):174-175. DOI: 10.3969/j.issn.2096-2479.2017. 38.145.
[11] 邓小芳,吴莹莹,陈柳霏,等. 综合护理干预在肺癌晚期患者疼痛及睡眠质量的应用价值[J]. 国际医药卫生导报,2023,29(14):2059-2062. DOI: 10.3760/cma.j.issn.1007-1245. 2023.14.031.
[12] Gong K, Zhou H, Liu H, et al. Identification and integrate analysis of key biomarkers for diagnosis and prognosis of non-small cell lung cancer based on bioinformatics analysis[J].Technol Cancer Res Treat, 2021, 20: 15330338211060202. DOI: 10.1177/15330338211060202.
[13] Sepesi B, Cascone T, Chun SG, et al. Emerging therapies in thoracic malignancies-immunotherapy, targeted therapy, and T-cell therapy in non-small cell lung cancer[J]. Surg Oncol Clin N Am, 2020, 29(4): 555-569. DOI: 10.1016/j.soc.2020.06.009.
[14] Ratnakumaran R, McDonald F. The management of oligometastases in non-small cell lung cancer - is stereotactic ablative radiotherapy now standard of care?[J].Clin Oncol (R Coll Radiol), 2022,34(11): 753-760. DOI: 10.1016/j.clon.2022.08.033.
[15] Hochberg MC, Carrino JA, Schnitzer TJ, et al. Long-term safety and efficacy of subcutaneous tanezumab versus nonsteroidal antiinflammatory drugs for hip or knee osteoarthritis: a randomized trial[J]. Arthritis Rheumatol, 2021 ,73(7):1167-1177. DOI: 10.1002/art.41674.
[16] Berenbaum F, Blanco FJ, Guermazi A, et al. Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period [J]. Ann Rheum Dis, 2020,79(6): 800-810. DOI: 10.1136/annrheumdis- 2019-216296.
[17] 柴春维,张华云,张圆圆. 延伸护理用于癌症化疗护理中的效果分析[J]. 系统医学,2021,6(12): 158-160,164. DOI: 10.19368/j.cnki.2096-1782.2021.12.158.
[18] 娄正磊. 个案管理的延伸护理服务在老年非小细胞肺癌化疗患者中的应用观察[J]. 疾病监测与控制,2020,14(5):382-385. DOI:10.19891/j.issn1673-9388.(2020)05-0382 -04.
[19] 闫艳,潘静,李杰. 延伸护理对肺癌患者生存质量以及认知功能的影响[J]. 中国医药指南,2020,18(4):220-221. DOI: 10.15912/j.cnki.gocm.2020.04.177.
[20] 廖秀娥,兰花兰,刘凤彬. 延伸护理对肺癌疼痛患者出院后止痛药用药依从性的影响[J]. 中外医学研究,2019,17(36):115-117. DOI: 10.14033/j.cnki.cfmr.2019.36.049.
[21] 沈兰. 延伸护理对肺癌根治术后患者生活质量的影响[J]. 当代护士(中旬刊),2019,26(8):102-104.
[22] 吴芬芳.院外延伸护理对老年肺癌术后患者生存质量的影响[C]//上海市护理学会.第四届上海国际护理大会论文汇编, 2019: 305.
[23] Smith TG, Strollo S, Hu X, et al. Understanding long-term cancer survivors' preferences for ongoing medical care[J]. J Gen Intern Med, 2019 ,34(10):2091-2097. DOI: 10.1007/s11606-019-05189-y.
[24] 董艳,董喆,孟醒,等. 心理支持护理联合意向放松训练在中晚期肺癌患者中的应用[J]. 河南大学学报(医学版), 2021,40(6):437-440. DOI: 10.15991/j.cnki.41-1361/r.2021. 06.010.
[25] 翟蕾,段淑敏,韩玲玉,等.老年重症心力衰竭患者的个性化护理效果和护理质量评价[J].河南大学学报(医学版),2021,40(2):126-128, 142. DOI: 10.15991/j.cnki.41-1361/r.2021.02.011.